Autoimmune disease refers to disease where immune system produces antibodies that kill or attack healthy cells or tissues. The immune system work is to provide protection against germs such as bacteria and virus. In autoimmune disease immune system wrongly attacks patients body. According to American Autoimmune Related Diseases Association, autoimmune disease affects fifty million Americans in which 25% are male and 75% are female. The Global Autoimmune Disease Diagnostic Market is expected to surpass US$ 18 Billion by the year end of 2025.
Although there are 80 Types of Autoimmune Diseases, but 14 most Common Autoimmune Diseases are as follows:
Rheumatoid Arthritis, Psoriasis/psoriatic arthritis, Multiple sclerosis, Type 1 diabetes, Inflammatory bowel disease, Systemic Lupus Erythematosus (SLE), Addison’s disease, Sjögren’s syndrome, Graves’ disease, Hashimoto’s thyroiditis, Myasthenia gravis, Autoimmune vasculitis, Celiac disease, Pernicious anemia.
Factors Driving the Autoimmune Disease Diagnostic Market
Rising technological advancement in diagnostic, increasing patient awareness towards early diagnostic of disease, increasing government healthcare expenditure, increasing per capita expenditure on health, favorable government policies, industry positive initiative towards autoimmune disease and rising research & development on autoimmune will further propel the market of autoimmune disease diagnostic market in the future course of time.
Segment Insight by Disease
In this report, we have categorized the autoimmune disease diagnostic market on the basis of disease into two parts; Systemic autoimmune disease diagnostics and Localized autoimmune disease diagnostics. Systemic autoimmune disease diagnostics market are further fragmented into three parts; Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Rheumatoid Arthritis. In addition, we have also explained the technological development of autoimmune diagnostic.
Autoantibody Tests is one of the Largest Test of Autoimmune Disease Diagnostic Tests
In this report, we have categorized the autoimmune disease diagnostic market by test type into seven parts along with comprehensive assessment and factor that will boost the diagnostic test market. These tests are Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis and Comprehensive Metabolic Panel.
Regional Insight – North America is the Most Important Region for Autoimmune Disease Diagnostic Market
In this report, we have segmented the autoimmune disease diagnostic test market on the basis of four important regions; North America, Europe, Asia-Pacific and ROW. In addition, we have also done the multi-factor analysis for regional growth of autoimmune disease diagnostic market
Companies Analysis
Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.
All the 7 Companies Studied in the Report have been Studied from 3 Points
Company Overview
Business Strategy /Mergers & Acquisition
Financial Insight
This report provides a complete analysis of the Autoimmune Disease Diagnostic Market, Growth Drivers, Challenges, and their projections for the upcoming years.
Autoimmune Disease Diagnostic Segments Covered in the Report:
Systemic autoimmune disease diagnostics market
Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus (SLE)
Others
'
1. Executive Summary
2. Global Autoimmune Diseases Diagnostic Market
3. Market Share – Global Autoimmune Diseases Diagnostic
3.1 By Disease – Global Autoimmune Diseases Diagnostic
3.2 By Disease – Systemic Autoimmune Diseases Diagnostic
3.3 By Region – Global Autoimmune Diseases Diagnostic
4. By Disease - Global Autoimmune Diseases Diagnostic Market
4.1 Systemic Autoimmune Disease
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Systemic Lupus Erythematosus (SLE)
4.1.4 Others
4.2 Localized Autoimmune Disease Diagnostics
4.2.1 Inflammatory Bowel Disease
4.2.2 Type 1 Diabetes
4.2.3 Thyroid
4.2.4 Other Localized Autoimmune Diseases
5. By Test Type - Global Autoimmune Diseases Diagnostic Market
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. By Region - Global Autoimmune Diseases Diagnostic Market
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Rest of the World (ROW)
7. Abbott Laboratories – Company Analysis
7.1 Overview
7.2 Business Strategy
7.2.1 Point A
7.2.2 Point B
7.2.3 Point D
7.2.4 Point E
7.3 Financial Insight
8. Siemens Healthineers – Company Analysis
8.1 Overview
8.2 Business Strategy
8.2.1 Point A
8.2.2 Point B
8.2.3 Point C
8.3 Financial Insight
9. Roche Diagnostics – Company Analysis
9.1 Overview
9.2 Roche Holding AG Key Development
9.3 Business Strategy
9.3.1 Point A
9.3.2 Point B
9.3.3 Point C
9.4 Financial Insight
10. EUROIMMUN AG – Company Analysis
10.1 Overview
10.2 Business Strategy
10.2.1 Point A
10.2.2 Point B
10.3 Financial Insight
11. bioMerieux SA – Company Analysis
11.1 Overview
11.2 Business Strategy
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.3 Financial Insight
12. Quest Diagnostic – Company Analysis
12.1 Overview
12.2 Business Strategy
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.2.4 Point D
12.2.5 Point E
12.3 Financial Insight
13. Bio-Rad Laboratories – Company Analysis
13.1 Overview
13.2 Business Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Financial Insight
14. Growth Drivers
14.1 Rising Incidence of Autoimmune Diseases
14.2 High Occurrence of Rheumatoid Arthritis
15. Challenges
15.1 Industry Challenges by Product Differentiation
15.2 High Costs of Equipment for Diagnosis of Autoimmune Diseases
